calendar

6,403 catalysts · 5,990 phase readout · 2,344 8k filing · 413 earnings · 3 pdufa · 2 approval · 1 adcom

next 91 dayslessmore

MonWedFri

view

sort

type

therapy area

no tagged catalysts yet

Date TBD

›WITHHELDphase readoutNCT06042101: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

›RECRUITINGphase readoutNCT07402512: A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children

Sponsor: Simcere Pharmaceutical Co., Ltd. Phase: PHASE3. Conditions: Respiratory Syncytial Virus Infection

›WITHDRAWNphase readoutNCT07375212: VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure

Sponsor: Prisma Health-Upstate. Phase: PHASE4. Conditions: Heart Failure Congestive

page 129 of 129